Aesthetics Devices Pipeline Product and Technology Analysis Report

Report Overview

Table of Contents

1430

Select License Type

£1,430.00	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£2,900.00	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£4,290.00	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£1,430.00	Add to Wishlist
Change Currency	GBP EURO USD

Market	Healthcare and Medical
Report Type	Market Research
Country	Global
Published	31 January 2009
Number of Pages	20
Report Delivery	Email
Delivery Lead Time	-
Publisher	Global Markets Direct

Aesthetics Devices Pipeline Product and Technology Analysis Report

Summary

The “Pipeline Products and Technology Analysis Report” is an essential source of information and analysis on pipeline medical devices, which are expected to bring significant shift to the prevalent market landscape. We keep our subscribers abreast of the very latest technological developments by providing them with our independent and unbiased judgment on the implications of each development within the industry. While the objective is to review specific pipeline devices and technologies, the report also provides a holistic overview of the existing products, the market structure and the competitive landscape.

Scope

• Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally;
• Independent analysis of the product details, indication details and clinical trial status with projections on the market potential;
• Review of existing competing technologies and the competitive landscape;
• Review and analysis of the trends, drivers and restraints shaping and defining the markets that the products are being targeted in;
• In-depth analysis of the device-specific developments, strategic partnerships and other details expected to influence the launch and market penetration.

Reasons to buy

• Effectively plan your M&A and partnership strategies by identifying companies with the most promising pipeline;
• Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies;
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage; and
• Stay ahead of competition by understanding the changing competitive landscape in specific geographies.

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

£1,430.00	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£2,900.00	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£4,290.00	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£1,430.00	Add to Wishlist
Change Currency	GBP EURO USD

1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Aesthetics Devices Pipeline Product and Technology Analysis 8
2.1 Summary 8
3 Aesthetics Devices: Overview 9
3.1 Aesthetic Devices: Market Overview 9
3.2 Aesthetic Devices: Technology Overview 9
3.2.1 Intense Pulsed Light (IPL) 9
3.2.2 Laser Emitting Diode (LED) for Aesthetic Use 10
3.2.3 Radio Frequency For Aesthetic Use 11
3.2.4 Collagen Implants 11
4 Aesthetic Devices Market 12
4.1 Overview 12
4.2 Aesthetic Devices Market: Trend Analysis 14
4.2.1 Market Drivers 14
4.2.2 Market Restraints 14
4.3 Aesthetic Devices Market: Competitive Landscape 15
5 Aesthetics Devices Pipeline Products 16
5.1 SeriGel 16
5.1.1 Product Status 16
5.1.2 Product Description 16
5.2 Mediostar Effect 16
5.2.1 Product Status 16
5.2.2 Product Description 17
5.2.3 Mediostar Effect Clinical Trials 1 17
5.2.4 Mediostar Effect Clinical Trials 2 18
5.2.5 Mediostar Effect Clinical Trials 3 18
5.2.6 Mediostar Effect Clinical Trials 4 18
5.2.7 Mediostar Effect Clinical Trials 5 19
5.2.8 Mediostar Effect Clinical Trials 6 19
5.2.9 Mediostar Effect Clinical Trials 7 19
5.3 Dermablate Effect 20
5.3.1 Product Status 20
5.3.2 Product Description 20
5.3.3 Dermablate Effect Clinical Trials 1 21
5.3.4 Dermablate Effect Clinical Trials 2 21
5.3.5 Dermablate Effect Clinical Trials 3 22
5.3.6 Dermablate Effect Clinical Trials 4 22
5.4 Tattoo Star Effect 23
5.4.1 Product Status 23
5.4.2 Product Description 23
5.4.3 TattooStar Effect Clinical Trials 1 24
5.4.4 TattooStar Effect Clinical Trials 2 24
5.5 Ultrasound device 25
5.5.1 Product Status 25
5.5.2 Product Description 25
5.6 Contour Plus 26
5.6.1 Product Status 26
5.6.2 Product Description 26
5.6.3 Contour Plus Clinical Trials 1 26
5.6.4 Contour Plus Clinical Trials 2 27
5.6.5 Contour Plus Clinical Trials 3 27
5.6.6 Contour Plus Clinical Trials 4 27
5.7 Haptized Collagen Tissue Augmentation 28
5.7.1 Product Status 28
5.7.2 Product Description 28
5.8 LipoSonix Technology 29
5.8.1 Product Status 29
5.8.2 Product Description 29
5.8.3 LipoSonix Technology Clinical Trials 1 29
5.8.4 LipoSonix Technology Clinical Trials 2 30
5.8.5 LipoSonix Technology Clinical Trials 3 30
5.8.6 LipoSonix Technology Clinical Trials 4 31
5.9 Isolagen Therapy 32
5.9.1 Product Status 32
5.9.2 Product Description 32
5.9.3 Isolagen Therapy Clinical Trials 1 32
5.9.4 Isolagen Therapy Clinical Trials 2 33
5.9.5 Isolagen Therapy Clinical Trials 3 34
5.9.6 Isolagen Therapy Clinical Trials 4 35
5.9.7 Isolagen Therapy Clinical Trials 5 36
5.9.8 Isolagen Therapy Clinical Trials 6 37
5.10 Dermal Bead 38
5.10.1 Product Status 38
5.10.2 Product Description 38
5.10.3 Clinical Trials 39
5.11 VOLUMA 39
5.11.1 Product Status 39
5.11.2 Product Description 39
5.12 Plasma Skin Regeneration 40
5.12.1 Product Status 40
5.12.2 Product Description 40
6 Future Outlook 41
7 Global Aesthetic Devices Pipeline Product Summary 42
8 Global Aesthetic Devices Clinical Trial Summary 44
9 Appendix 47
9.1 Research Methodology 47
9.2 Secondary Research 48
9.3 Primary Research 48
9.4 Models 48
9.5 Forecasts 49
9.6 Expert Panels 49
9.7 GlobalData Consulting 49
9.8 Contact Us 49
9.9 Disclaimer 50

1.1 List of Tables
Table 1: Indications Treatable with IPL 10
Table 2: Aesthetic Devices Market, Global, Value ($m), 2004 – 2012 12
Table 3: Top Non–Surgical Aesthetic Procedures, US, 2007 13
Table 4: Top Surgical Aesthetic Procedures, US, 2007 13
Table 5: SeriGel, Product Status 16
Table 6: SeriGel, Product Description 16
Table 7: Mediostar Effect, Product Status 16
Table 8: Mediostar Effect, Product Description 17
Table 9: Mediostar Effect Clinical Trials 1 17
Table 10: Mediostar Effect Clinical Trials 2 18
Table 11: Mediostar Effect Clinical Trials 3 18
Table 12: Mediostar Effect Clinical Trials 4 18
Table 13: Mediostar Effect Clinical Trials 5 19
Table 14: Mediostar Effect Clinical Trials 6 19
Table 15: Mediostar Effect Clinical Trials 7 19
Table 16: Dermablate Effect, Product Status 20
Table 17: Dermablate Effect, Product Description 20
Table 18: Dermablate Effect Clinical Trials 1 21
Table 19: Dermablate Effect Clinical Trials 2 21
Table 20: Dermablate Effect Clinical Trials 3 22
Table 21: Dermablate Effect Clinical Trials 4 22
Table 22: TattooStar Effect, Product Status 23
Table 23: TattooStar Effect, Product Description 23
Table 24: TattooStar Effect Clinical Trials 1 24
Table 25: TattooStar Effect Clinical Trials 2 24
Table 26: Ultrasound device, Product Status 25
Table 27: Ultrasound device, Product Description 25
Table 28: Contour Plus, Product Status 26
Table 29: Contour Plus, Product Description 26
Table 30: Contour Plus Clinical Trials 1 26
Table 31: Contour Plus Clinical Trials 2 27
Table 32: Contour Plus Clinical Trials 3 27
Table 33: Contour Plus Clinical Trials 4 27
Table 34: Haptized Collagen Tissue Augmentation, Product Status 28
Table 35: Haptized Collagen Tissue Augmentation, Product Description 28
Table 36: LipoSonix Technology, Product Status 29
Table 37: LipoSonix Technology, Product Description 29
Table 38: LipoSonix Technology Clinical Trials 1 29
Table 39: LipoSonix Technology Clinical Trials 2 30
Table 40: LipoSonix Technology Clinical Trials 3 30
Table 41: LipoSonix Technology Clinical Trials 4 31
Table 42: Isolagen Therapy, Product Status 32
Table 43: Isolagen Therapy, Product Status 32
Table 44: Isolagen Therapy Clinical Trials 1 32
Table 45: Isolagen Therapy Clinical Trials 2 33
Table 46: Isolagen Therapy Clinical Trials 3 34
Table 47: Isolagen Therapy Clinical Trials 4 35
Table 48: Isolagen Therapy Clinical Trials 5 36
Table 49: Isolagen Therapy Clinical Trials 6 37
Table 50: Dermal Bead, Product Status 38
Table 51: Dermal Bead, Product Description 38
Table 52: Dermal Bead Clinical Trials 1 39
Table 53: VOLUMA, Product Status 39
Table 54: VOLUMA, Product Description 39
Table 55: Plasma Skin Regeneration, Product Status 40
Table 56: Plasma Skin Regeneration, Product Description 40
Table 57: Global Aesthetic Devices, Pipeline Product Summary 42
Table 58: Global Aesthetic Devices, Clinical Trial Summary 44

1.2 List of Figures
Figure 1: Aesthetic Devices Market, Global, Value ($m), 2004 – 2012 12
Figure 2: Percentage of Population Over The Age Of 65 Years 14
Figure 3: GlobalData Methodology 47

Change Currency

GBP

EURO

USD

Last Viewed

Aesthetics Devices Pipeline Product and Technology Analysis Report

The French approach: an alternative model for broadband deployment

Sociedad Quimica y Minera de Chile SA - Financial Analysis Review

Accuitive Medical Ventures - Medical Equipment - Investment Profile

Nippon Express Co., Ltd. - Financial and Strategic Analysis Review

Healthcare and Medical Company Profiles

Healthcare and Medical Company Profiles contain up to date financial, strategic, operational, SWOT analysis and product information on the activities of thousands of healthcare and medical companies.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Healthcare and Medical	Type	Keywords Phrase All Words Any Word
Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.	Country	Industry Sector
Publisher	Order By Relevance Date	Published In

Aesthetics Devices Pipeline Product and Technology Analysis Report

Select License Type

Speak to an Advisor

Select License Type

Table of Contents

Change Currency

Last Viewed

Healthcare and Medical Company Profiles

Become an Affiliate

Custom Research

News

Market Insights

Companies And Markets

Customer Support

Corporate Accounts

Contact Details

Contrast settings

Text size settings

All
Afghanistan
Africa
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Asia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Bouvet Island
Brazil
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean
Cayman Islands
Central African Republic
Central America
Central Europe
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Conch Republic
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of Congo
Denmark
Djibouti
Dominica
Dominican Republic
Eastern Europe
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Europe
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Global
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guernsey
Guinea
Guinea Bissau
Guyana
Haiti
Heard Island and McDonald Islans
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Ivory Coast (Cote D`Ivoire)
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kurdistan
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Middle East
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North America
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Scandinavia
Schengen countries
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South America
South Georgia and the South Sandwich Islands
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste (East Timor)
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe

All
Aerospace
Agriculture, Farming & Raw Materials
Automotive and Parts
Business Services
Chemicals
Construction
Consumer Goods
Defence
Energy and Utilities
Environmental
Finance and Banking
Food and Drink
Healthcare and Medical
Industrial
Information Technology
Leisure
Logistics
Media
Paper and Packaging
Publishing and Printing
Real Estate
Retail
Security
Telecommunications
Textiles and Clothing
Transportation
Travel